Brunswick is a corporate communications partnership. We provide informed advice at a senior level to businesses and other organizations around the world; helping them to address critical communications challenges that may affect their valuation, reputation or ability to achieve their ambitions.
Worldwide, we are one firm, a private partnership that has grown organically, person-by-person, from three Partners in one office in 1987 to over 50 Partners and 40 Directors in nine offices around the world today. In total, we are 300 people. Our predominance of senior professionals from a range of industry backgrounds gives us a significant competitive advantage and our clients a significant benefit.
Our clients often face demanding issues and audiences. They look to us for a team of highly experienced and dedicated communications specialists working together as one firm. We advise more than 250 retained clients, including large multinationals, small private firms and voluntary bodies. Half our clients have been with us for more than five years; a fifth for more than ten years. We aim to deliver a result that is visible, valuable and earns the respect of our clients and their subsequent recommendation.
| Contact Details: |
| 140 East 45th Street30th Floor |
| New York |
| New York |
| 10017 |
| United States of America |
| Tel: | 1 212 333 3810 |
| Fax: | 1 212 333 3811 |
| Email: | |
| WWW: | www.brunswickgroup.com/
|
|
Loading...
|
Press Releases on Brunswick Group LLC:
|
 |
| Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results |
12th March, 2009 |
Simcere Pharmaceutical Group |
NANJING, China, March 12 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group
("Simcere" or the "Company') (NYSE: SCR), a leading manufacturer and supplier
of branded generic
|
| Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008 |
27th October, 2008 |
Simcere Pharmaceutical Group |
NANJING, China, Oct. 27 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical
Group (NYSE: SCR), a leading manufacturer and supplier of branded generic
pharmaceuticals and innovative anti-cancer
|
| /C O R R E C T I O N -- Simcere Pharmaceutical Group/ |
5th September, 2008 |
Simcere Pharmaceutical Group |
In the news release, ''Simcere Pharmaceutical Group Announces Interim
Results of Endu Phase IV Clinical Study'', issued on Sept. 3 by Simcere
Pharmaceutical Group (NYSE: SCR)
|
| Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study |
3rd September, 2008 |
Simcere Pharmaceutical Group |
NANJING, China, Sept. 3 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical
Group (NYSE: SCR), a leading manufacturer and supplier of branded generic
pharmaceuticals and manufacturer of the patented
|
| Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008 |
15th July, 2008 |
Simcere Pharmaceutical Group |
NANJING, China, July 15 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical
Group (NYSE: SCR), a leading manufacturer and supplier of branded generic
pharmaceuticals and innovative anti-cancer
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1171 times since April 2007, the link to the organisation's website has been followed 191 times
Recent Search Terms used to find this page: brunswick group llc | Brunswick Group LLC | Brunswick Group LLC | Brunswick Group Logo | brunswick group goldman sachs | BRUNSWICK GROUP LLC | Brunswick Group LLC | brunswick group llc | brunswick group llc | the brunswick group nj url | .
Search for more companies in New York
Search for more companies in New York
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Brunswick Group LLC
